Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study.
Luca ZanellaGiacomo ZoppellaroLucia MarigoGentian DenasSeena Padayattil JoseVittorio PengoPublished in: Cardiovascular therapeutics (2018)
ICHs during VKA therapy preferentially occur in very elderly patients. The risk of ICH is not predicted by the commonly used risk scores.